Literature DB >> 31458362

Synthesis of Functionalized Thieno[2,3-b]indoles via One-Pot Reaction of Indoline-2-thiones with Morita-Baylis-Hillman and Rauhut-Currier Adducts of Nitroalkenes.

Vaijinath Mane1, Thekke V Baiju1, Irishi N N Namboothiri1.   

Abstract

A straightforward protocol for the synthesis of functionalized thieno[2,3-b]indoles by ban class="Chemical">se-mediated [3 + 2]-annulation of indoline-2-thione with Morita-Baylis-Hillman and Rauhut-Currier adducts of nitroalkenes is described. Complete regioselectivity, broad substrate scope, and mild reaction conditions make this strategy very valuable. Moreover, the thieno[2,3-b]indoles comprising functional groups such as hydrazine and ketoalkyl moieties are amenable for further synthetic elaboration.

Entities:  

Year:  2018        PMID: 31458362      PMCID: PMC6643647          DOI: 10.1021/acsomega.8b02147

Source DB:  PubMed          Journal:  ACS Omega        ISSN: 2470-1343


Introduction

Organosulfur compounds exhibit drug-like properties and thus they have been widely exploin class="Chemical">ted for medicinal chemistry applications.[1] Thiophene and their fused analogues stand out among various sulfur-containing compounds because of their excellent medicinal properties.[2] The indole-annulated thiophene, particularly, thieno[2,3-b]indole, constitutes a privileged structural motif and has gained considerable attention among synthetic and medicinal chemists.[3] Structures of some of the bioactive indole-annulated thiophene derivatives are listed in Figure . The core structure, thieno[2,3-b]indole A exhibits antifungal activity[4] and the substituted thieno[2,3-b]indoles have potential medicinal applications for the treatment of neurological diseases such as epilepsy, senile dementia, Parkinson’s disease, and deficiencies of mental and motoric performance observed after conditions of brain ischemia.[5] Also, the natural product thienodolin B has the same structural framework which displays plant growth-promoting and -inhibiting activities in rice seedlings.[3,6] In addition to their pronounced pharmacological properties, some of these scaffolds (D–G) are also employed in organic electronics as electroluminescent materials[7] and in the field of conducting polymers (H, Figure ).[8]
Figure 1

Bioactive (A–C) and functional materials (D–H) containing the thieno[2,3-b]indole skeleton.

Bioactive (A–C) and functional materials (D–H) containing the n class="Chemical">thieno[2,3-b]indole skeleton. Owing to their wide range of biological and electronic material applications, various synthetic methods have been developed for the synthesis of n class="Chemical">thieno[2,3-b]indole skeletons.[9] The prominent strategies include deoxygenative or palladium-catalyzed reductive cyclization of 3-(2-nitrophenyl)thiophenes,[10] electrophilic cyclization of 2-alkyl-5-(2-isothiocyanoaryl)furans in the presence of AlCl3,[11] oxidative cycloamination of benzothiophenes,[12] radical or palladium-catalyzed cyclization of 3-(2-bromoindol-3-yl)acrylonitriles,[13] Paal–Knorr cyclization of oxindoles in the presence of Lawesson’s reagent,[14] and so forth. Recently, Deng et al. demonstrated efficient methods for the regioselective synthesis of thieno[2,3-b]indoles by Brønsted acid-promoted multicomponent reactions.[15] Indoline-2-thione has been recognized as a suitable binucleophilic synthon for the synthesis of various n class="Chemical">indole-annulated heterocycles,[16] and few reports are also available for the synthesis of thieno[2,3-b]indoles starting from indoline-2-thione.[17] Although many elegant methods are documented in the literature, the development of novel and efficient diversity-oriented strategies for the construction of functionalized indole-annulated thiophenes are still desirable considering their synthetic and biological significance. Our group has long-term interest in the Morita–Baylis–Hillman (MBH)[18] and Rauhut–Currier (RC)[19] reactions of nitroalkenes and their applications toward the synthesis of several carbo- and heterocycles.[20] Specifically, α-hydrazinonitroalkenes prepared via MBH reaction of nitroalkenes with azodicarboxylates[21] and an RC adduct of nitroalkene with MVK[22] are well utilized as synthons for the preparation of several functionalized carbo- and heterocycles.[23,24] These are excellent Michael acceptors which participate in cascade Michael addition–cyclization sequences.[22−26] There is also the possibility of further exploitation of the reactivity of hydrazino and ketoalkyl moieties that are retained in the products. α-Hydrazinonitroalkenes were employed as substrates for the synthesis of functionalized triazoles and arenofurans,[23] whereas pyrazoles, furans, decalins, cycloalkanones, spirocycles, and a bridged heterobicyclic compound epibatidine were efficiently synthesized from RC-adducts.[22,24,25] Very recently, we reported an effective strategy for the synthesis of aminophenanthrenes and benzoquinolines from RC-adducts of nitroalkenes using Hauser–Kraus reaction of sulfonyl phthalide as the key step.[26] As part of our ongoing program to synthesize functionalized heterocycles, herein, we report a novel approach for the construction of indole-annulated thiophenes from MBH/RC-adducts of nitroalkenes and indoline-2-thione.

Results and Discussion

Our investigation commenced with a model reaction between N-methylated n class="Chemical">indoline-2-thione 1a and hydrazinated nitroalkene 2a in the presence of a mild base such as KOAc at room temperature (Table , entry 1). The desired product, fused thienoindole 4a, was formed in 75% yield after 4 days of stirring. The role of inorganic and organic bases was studied to improve the yield in short reaction time. When the reaction was carried out in the presence of inorganic bases such as K2CO3, Cs2CO3, and NaOH, instead of the expected aromatized fused thienoindole, the dihydrothienoindole 3a was formed in 58, 27 and 62% yields, respectively, in a relatively short reaction period (Table , entries 2–4). Subsequently, the role of an organic base was evaluated by performing the reaction in the presence of Et3N. In this case also the reaction exclusively furnished the dihydrothienoindole 3a in 62% yield (Table , entry 5). Among several bases screened, only KOAc delivered the desired product. After successful screening of bases, we have investigated the effect of solvents by using the optimized base KOAc. A brief evaluation of solvents was then performed by conducting the reaction in tetrahydrofuran (THF), methanol, and toluene (entries 6–8). Among the solvents screened, THF and methanol provided the desired product 4a after 8 d of reaction, but the yield was inferior as compared to that in CH3CN (entry 1). When the reaction was carried out in the presence of 1 mol % acid additive, viz, acetic acid, the yield improved to 78% and the reaction was completed in 4 days. These reaction conditions were the best for this transformation (Table , entry 9).
Table 1

Optimization Studiesa

    % yieldb
entrybasesolventtime3ac4a
1KOAcCH3CN4 d 75
2K2CO3CH3CN30 min58 
3Cs2CO3CH3CN30 min27 
4NaOHCH3CN25 min62 
5Et3NCH3CN25 min62 
6KOAcTHF8 d 60
7KOAcMeOH8 d 63
8KOActoluene8 d  
9KOAcCH3CN4 d 78d

Reaction scale: 1a (0.25 mmol, 1.0 equiv), 2a (0.25 mmol, 1.0 equiv), base (0.25 mmol, 1.0 equiv), and solvent (3 mL) at RT.

After silica gel column chromatography.

Slowly gets converted to 4a during purification and upon storage; prolonging the reaction time beyond the indicated time or heating to 60–80 °C in the case of entries 2–5 led to complex mixtures.

Acetic acid as the additive (1 mol %).

Reaction scale: 1a (0.25 mmol, 1.0 equiv), 2a (0.25 mmol, 1.0 equiv), base (0.25 mmol, 1.0 equiv), and solvent (3 mL) at RT. After silica gel column chromatography. Slowly gets converted to 4a during purification and upon storage; prolonging the reaction time beyond the indican class="Chemical">ted time or heating to 60–80 °C in the case of entries 2–5 led to complex mixtures. Acetic acid as the additive (1 mol %). After establishing the best reaction conditions for this transformation, we have investigan class="Chemical">ted the generality of the reaction (Table ). Various N-substituted indoline-2-thiones 1 and different hydrazinonitroalkenes 2 were well tolerated, and the thienoindole derivatives 4 were formed in moderate to good yields. The electronic nature of groups present on the aryl ring of hydrazinonitroalkenes 2 did not influence the product yield. The hydrazinonitroalkenes 2a and 2c bearing an isopropyl ester moiety and weakly and strongly electron-donating para-substituted aryl groups on reaction with 1a afforded the corresponding products 4a and 4c in 78 and 66% yield (entries 1 and 3), respectively. Likewise, the hydrazinonitroalkene 2e having a weakly electron-withdrawing aryl substituent also produced the product 4e in 66% yield (entry 5). Comparable to those bearing electron-donating and electron-withdrawing aryl groups, a lower yield (58%) was obtained in the case of the electron-neutral substrate 2b (entry 2). The methodology was further generalized with the heterocycle-substituted hydrazinonitroalkene 2f, which also reacted smoothly with 1a to provide the desired fused thienoindole derivative 4f in 40% yield (entry 6). Additionally, the bulky tert-butyl dicarboxylate-containing hydrazinonitroalkene 2d is also compatible for this transformation and delivered 4d in 75% yield (entry 4).
Table 2

Synthesis of Thienoindole 4 by Cascade Reaction of Indoline-2-thione 1 with Hydrazinonitroalkene 2a

entry1, R2, ArR13 or 4time% yieldb
11a, Me2a, 4-MeC6H4iPr4a4 d78
21a, Me2b, C6H5iPr4b4 d58
31a, Me2c, 4-OMeC6H4iPr4c2 d66
41a, Me2d, 4-OMeC6H4tBu4d3 d75
51a, Me2e, 4-ClC6H4iPr4e3 d66
61a, Me2f, 2-thienyliPr4f3 d40c
71b, Et2a, 4-MeC6H4iPr4g8 d43c
81c, nPr2a, 4-MeC6H4iPr4h7 d65
91d, Bn2a, 4-MeC6H4iPr4i8 d64
101a, Me2a, 4-MeC6H4iPr3a3 h46d
111a, Me2g, CyiPr4j1 de

Reaction scale: 1 (0.7 mmol, 1.0 equiv), 2 (0.7 mmol, 1.0 equiv), KOAc (0.7 mmol, 1.0 equiv), and acetic acid (0.4 μL, 1 mol %) in CH3CN (3 mL) at RT.

After silica gel column chromatography.

10–20% of 1 and 2 was recovered; prolonged reaction led to a complex mixture.

Short reaction time allows isolation of the product before aromatization in this case.

Complex mixture.

Reaction scale: 1 (0.7 mmol, 1.0 equiv), 2 (0.7 mmol, 1.0 equiv), KOAc (0.7 mmol, 1.0 equiv), and n class="Chemical">acetic acid (0.4 μL, 1 mol %) in CH3CN (3 mL) at RT. After silica gel column chromatography. 10–20% of 1 and 2 was recovered; prolonged reaction led to a complex mixture. Short reaction time allows isolation of the product before aromatization in this case. Complex mixture. Next, the substrate scope with regard to N-substitun class="Chemical">ted indoline-2-thione was studied. It was found that various N-protected thioindoles 1b–d, including ethyl, n-propyl, and benzyl, reacted efficiently and provided the desired products in decent to good yields (43–64%) (Table , entries 7–9). It is worth to stress that the synthesis of desired aromatized thienoindoles requires a prolonged reaction time (2–8 days), but it is impressive by considering the outcome of the reaction. When the reaction was allowed to proceed for short  time, for instance, the reaction of N-methylated indoline-2-thione 1a with hydrazinonitroalkene 2a under the optimized reaction conditions provided dihydrothienoindole 3a in 46% yield after 3 h (Table , entry 10). Unfortunately, hydrazinonitroalkenes bearing an alkyl group such as cyclohexyl as in 2g was not suitable for our reaction (Table , entry 11). The synthesized indole-annulan class="Chemical">ted thiophene derivatives 4a–i were characterized by usual spectroscopic analyses. In most cases, these compounds showed signal broadening in the NMR spectrum because of the presence of rotamers. The partial double bond character of carbamate in the hydrazine moiety is responsible for the existence of rotamers, and additionally, the quadrupolar effect of N-atoms present in the hydrazine moiety complicates the NMR spectra (Scheme ). To study this dynamic NMR phenomenon, variable-temperature 1H NMR experiments were conducted by taking 4g as the representative compound (Figure ). The spectra were recorded in the range of 296–328 K, but only marginal changes were observed in the spectral pattern. Although the signals for most of the aromatic and N–Et protons were reasonably well resolved and methyl protons of the isopropyl group remained unresolved at all of the temperatures studied, gradual resolution of one of the isopropyl methine protons resonating at 4.98–5.08 ppm was discernible upon increasing the temperature. A similar resolution was observed for two of the aromatic protons resonating at ∼7.50 ppm. The two broad signals appearing at ∼7.00 and 6.85 ppm in approximately 2:1 ratio, assigned for the N–H of two rotamers, in the spectrum recorded at 296 K coalesce at 313 K and become sharper at higher temperature. Overall, the sharper signals observed for the protons upon increasing the temperature are attributed to faster rotation about the C–N bond. Furthermore, the structure and regiochemistry of both indole-fused thiophenes and dihydrothienoindole were established by single-crystal X-ray analysis of compounds 4h and 3a (Figure ).
Scheme 1

Possible Isomers of 4g

Figure 2

Variable-temperature 1H NMR spectra of 4g recorded at different temperatures in the range 296–328 K.

Figure 3

ORTEP representation of compounds 3a and 4h.

Variable-temperature 1H NMR spectra of 4g recorded at different temperatures in the range 296–328 K. ORTEP representation of compounds 3a and 4h. On the basis of the results obtained and the literature precedents,[16,17] a logical mechanism for the formation of n class="Chemical">indole-annulated thiophene 4 is proposed in Scheme . The anion, generated from indoline-2-thione 1 by abstraction of a proton from C-3 position, adds in a Michael fashion to hydrazinonitroalkene 2, which is activated by AcOH via H-bonding, leading to the formation of intermediate I. The lone pair of electrons on the nitrogen atom of the hydrazine moiety participates in the elimination of the nitro group in intermediate I and generates a transient acyliminium-type intermediate II. Subsequently, the intramolecular cyclization of II occurs in a 5-exo-trig fashion, resulting in the formation of dihydrothienoindole 3 which on air oxidation gives the desired aromatized thienoindole 4. Alternatively, the reaction can proceed in another pathway starting from intermediate I. Thio-enolization of I followed by intramolecular 5-exo-tet cyclization and subsequent air oxidation results in the formation of thieno[2,3-b]indole 4 (Scheme ).
Scheme 2

Mechanism of Formation of Thienoindole 4 from Hydrazinonitroalkene 2 and Indoline-2-thione 1

To further demonstrate the scope of the developed method for the synthesis of diversely functionalized fused thienoindoles, we employed the RC adduct of nitroalkene 5 with MVK 5 as the reaction partner with indoline-2-thione 1. The initial reaction was performed by treating 1a with the RC adduct 5a under the established reaction conditions (Table , entry 1). As expected, the indole-annulated thiophene 6a was formed, but the yield was quite low (20%) after 19 h stirring at room temperature. To improve the yield of the reaction, optimization studies were conducted by varying the bases, solvents, and additives by choosing 1a and 5a as the model substrates. Initially, we screened several organic and inorganic bases in acetonitrile medium. When the reaction was carried out in the presence of an organic base, 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), the yield slightly improved to 44% in 1 h (Table , entry 2). Subsequent screening of milder inorganic bases such as K2CO3 and Cs2CO3 and stronger inorganic bases such as NaOH and KOBu revealed that the milder base K2CO3 promoted the reaction efficiently and delivered the product in 71% yield in 15 h (entries 3–6). Different solvents were then screened by selecting K2CO3 as the optimal base (entries 7–9). A considerable decline in yield was observed when the reaction was performed in other solvents such as THF, CHCl3, and toluene, and the initially employed medium CH3CN was found to be suitable for this transformation. Further, the loading of the base was varied which resulted in the formation of the product in reduced yield upon decreasing or increasing the amount of K2CO3 from 1 equiv (entries 10 and 11). Few additional experiments were performed by employing the additives such as LiCl and H2O (entries 12 and 13). The additive, LiCl was found to be inefficient for improving the yield (entry 12). The reaction was complete in 8 h and the yield improved (76%) when H2O was used as an additive (entry 13). When the reaction was performed under microwave irradiation at 40 °C, the reaction was complete in 15 min, but a substantial drop in yield (43%) was observed (entry 14). Finally, in terms of chemical yield and reaction time, entry 14 has been considered as optimal for this transformation. It may be noted that unlike in the reaction of thienoindole 1 with hydrazinonitroalkene 2, the aromatized fused thienoindole 6a was isolated in all of the cases when RC-adducts of nitroalkene 5a was employed.
Table 3

Optimization Studiesa

entrybase (equiv)time (h)solvent% yieldb
1KOAc (1.0)19CH3CN20
2DBU (1.0)1CH3CN44
3K2CO3 (1.0)15CH3CN71
4Cs2CO3 (1.0)15CH3CN57
5NaOH (1.0)4CH3CN50
6KOtBu (1.0)4CH3CN52
7K2CO3 (1.0)17THF45
8K2CO3 (1.0)18CHCl335
9K2CO3 (1.0)26toluene30
10K2CO3 (0.5)23CH3CN47
11K2CO3 (2.0)12CH3CN55
12K2CO3 (1.0) (LiCl)c15CH3CN44
13K2CO3(1.0) (H2O)d8CH3CN76e
14K2CO3 (1.0)15 minCH3CN43f

Reaction scale: 1a (0.23 mmol, 1.0 equiv), 5a (0.23 mmol, 1.0 equiv), and solvent (3 mL) at RT until complete consumption of at least one of the starting materials.

After column chromatography.

LiCl (0.23 mmol, 1.0 equiv).

CH3CN/H2O (97:3 v/v).

59% yield at 60 °C for 6 h.

Under microwave at 40 °C.

Reaction scale: 1a (0.23 mmol, 1.0 equiv), 5a (0.23 mmol, 1.0 equiv), and solvent (3 mL) at RT until complete consumption of at least one of the starting man class="Chemical">terials. After column chromatography. LiCl (0.23 mmol, 1.0 equiv). CH3CN/H2O (97:3 v/v). 59% yield at 60 °C for 6 h. Under microwave at 40 °C. With the optimal reaction conditions in hand, the scope of the reaction was investigated with different substitun class="Chemical">ted RC-adducts of nitroalkenes 5 and indoline-2-thiones 1. Initially, we focused on studying the reactivity of various substituted RC-adducts of nitroalkenes 5b–l, taking thienoindole 1a as the representative reaction partner, and the results are summarized in Table . In general, the electron-donating substituents on the aryl group of RC-adducts of nitroalkenes 5 afforded the thieno[2,3-b]indole derivatives 6 in low to moderate yields (28–51%, entries 2, 3, 5, and 6). In some cases, fairly good yields (59 and 70%) were obtained when multiple electron-donating groups were placed at different positions (entries 4 and 7). RC-adducts of nitroalkenes bearing weakly electron-withdrawing groups (5h–j) were also subjected to the reaction. While high yield (63%) was observed in the case of 4-chloro-substituted RC-adduct 5i, modest yields were obtained from RC-adducts 5h and 5j containing bromo- and fluoro substituents (entries 8–10). The RC-adduct of nitroalkene 5k containing bulky 1-naphthyl group also participated in the reaction and furnished the corresponding fused thienoindole derivative 6k in comparable yield. Notably, the heteroaryl-derived RC-adduct of nitroalkene 5l also reacted with 1a and delivered the product, though in low yield (31%).
Table 4

Synthesis of Thienoindoles (6a–l) from Indoline-2-thione 1a and Various Aryl-Substituted RC Adducts 5a

entry5, R6time (h)% yieldb
15a, C6H56a876
25b, 4-MeC6H46b937c
35c, 4-OMeC6H46c535c
45d, 3,4-(OMe)2C6H36d959
55e, 3-OMeC6H46e728c
65f, 3-(PhCH2O)C6H46f751
75g, 2,5-(OMe)2C6H36g970
85h, 4-BrC6H46h746c
95i, 4-ClC6H46i1263
105j, 4-FC6H46j748c
115k, 1-naphthyl6k756
125l, 2-thienyl6l831c

Reaction scale: 1a (0.75 mmol, 1.0 equiv), 5 (0.75 mmol, 1.0 equiv), K2CO3 (0.75 mmol, 1.0 equiv) in CH3CN and H2O (97:3 v/v, 3 mL) at RT.

After silica gel column chromatography.

10–20% 1a and 5 was recovered; prolonged reaction led to a complex mixture.

Reaction scale: 1a (0.75 mmol, 1.0 equiv), 5 (0.75 mmol, 1.0 equiv), K2CO3 (0.75 mmol, 1.0 equiv) in n class="Chemical">CH3CN and H2O (97:3 v/v, 3 mL) at RT. After silica gel column chromatography. 10–20% 1a and 5 was recovered; prolonged reaction led to a complex mixture. Subsequently, the scope of n class="Chemical">indoline-2-thione 1 was explored by reacting a representative RC-adduct 5a with different N-substituted and aryl-substituted thienoindoles 1 under the optimized conditions (Table ). Various N-protecting groups such as ethyl, n-propyl, and benzyl were tested. Among these, N-ethyl- and N-benzyl-protected indoline-2-thiones 1b and 1d afforded the product in excellent yields (87 and 94%, respectively, entries 1 and 3), whereas the N-propyl derivative 1c provided the corresponding product in much lower yield (entry 2). Indoline-2-thione 1e having chlorine on the aryl group (located at C-5 position) was subjected to reaction with 1a, and the expected product was isolated in moderate yield (44%, entry 4). It is noteworthy that the unprotected indoline-2-thione 1f is also compatible for this transformation and furnished the desired product in 44% yield (entry 5). Finally, the structures of thienoindoles 6a–q synthesized from RC-adducts 5a–l were characterized by analysis of their spectral data and further unambiguously confirmed by single-crystal X-ray analysis of a representative compound 6e (Figure ). (Table
Table 5

Synthesis of Thienoindoles (6m–q) from RC Adduct 5a and Differently Substituted Indoline-2-thiones 1a

entry1, RX6time (h)% yieldb
11b, EtH6m1287
21c, nPrH6n1255
31d, BnH6o1394
41e, MeCl6p544
51f, HH6q744

Reaction scale: 1a (0.75 mmol, 1.0 equiv), 5 (0.75 mmol, 1.0 equiv), K2CO3 (0.75 mmol, 1.0 equiv) in CH3CN, and H2O (97:3 v/v, 3 mL) at RT.

After silica-gel column chromatography.

Figure 4

ORTEP representation of compound 6e.

ORTEP representation of compound 6e. Reaction scale: 1a (0.75 mmol, 1.0 equiv), 5 (0.75 mmol, 1.0 equiv), K2CO3 (0.75 mmol, 1.0 equiv) in n class="Chemical">CH3CN, and H2O (97:3 v/v, 3 mL) at RT. After silica-gel column chromatography. A plausible mechanism for the one-pot synthesis of thiophene-annulan class="Chemical">ted indole derivatives 6 from RC-adducts is outlined in Scheme . The base-mediated Michael addition of indoline-2-thione 1 to the RC-adduct 5 generates intermediate I. Subsequently, an intramolecular thio-Mannich-type reaction occurs in a 5-exo-trig manner resulting in the intermediate II which undergoes elimination of HNO and H2O to afford the aromatized product 6.
Scheme 3

Mechanism of Formation of Thienoindole 6 from RC-Adduct 5 and Indoline-2-thione 1

Because the n class="Chemical">thieno[2,3-b]indole frameworks prepared from hydrazinonitroalkene 2 and RC-adducts 5 consist of functional moieties such as hydrazine and ketone, there exist enormous possibilities for further synthetic manipulation. The synthetic potential of these compounds was then highlighted by exemplifying a specific one-pot transformation of thieno[2,3-b]indole 4d containing a hydrazine ester moiety to pyrazole-tethered thieno[2,3-b]indole 8 (Scheme ). Acid hydrolysis of 4d followed by decarboxylation generated the corresponding hydrazine derivative which on reaction in situ with acetyl acetone (Knorr-pyrazole synthesis) provided 8, though in moderate yield (48%).
Scheme 4

Synthesis of Pyrazole-Tethered Thieno[2,3-b]indole

Conclusions

In summary, we have developed a convenient one-pot strategy for the synthesis of divern class="Chemical">se functionalized thieno[2,3-b]indoles from easily accessible starting materials. The base-mediated [3 + 2] annulation of indoline-2-thione and α-hydrazinonitroalkenes derived from the MBH-reaction of nitroalkenes and azodicarboxylates provided the functionalized indole-annulated thiophene motifs in moderate to excellent yields. In a similar fashion, the RC-adducts of nitroalkenes underwent cascade cyclization when reacted with indoline-2-thione and afforded corresponding indole-fused thiophenes in moderate to good yields. Although a prolonged reaction time was required for the construction of thieno[2,3-b]indoles bearing a hydrazine moiety (2–8 d), the mild and metal-free reaction conditions make this protocol quite attractive. Moreover, the hydrazine moiety on the thieno[2,3-b]indole skeleton could be transformed to pyrazole, which further broadens the synthetic applicability of the developed strategy. Studies to further extend the scope of the developed method for synthesizing novel heterocycle-fused indoles by employing various indolines and functionalized nitroalkenes are currently underway in our laboratory.

Experimental Section

General Information

The melting points recorded are uncorrected. NMR spectra (n class="Chemical">1H, 1H decoupled 13C, 19F, APT, 1H1H COSY) were recorded with tetramethylsilane as the internal standard. The coupling constants (J values) are given in Hz. IR spectra were recorded on a Fourier transform infrared spectrometer, and the values are expressed in cm–1. High-resolution mass spectra were recorded under ESI Q-TOF conditions. X-ray data were collected on a diffractometer equipped with graphite monochromated Mo Kα radiation. The structure was solved by direct methods shelxs97 and refined by full matrix least squares against F2 using shelxl97 software. The starting materials indoline-2-thiones,[27] MBH-adducts,[21] and RC-adducts[22] were prepared by literature methods.

General Procedure for the Synthesis of Thienoindole (4)

To a stirred solution of indoline-2-thione 1 (0.7 mmol, 1 equiv), KOAc (104 mg, 0.7 mmol, 1 equiv), and AcOH (0.4 μL, 1 mol %) in CH3CN (3 mL) at room temperature was added the MBH adduct 2 (0.7 mmol, 1 equiv). After the completion of the reaction [monitored by thin-layer chromatography (TLC)], the reaction mixture was concentrated in vacuo and the crude product was purified by silica gel (60–120 mesh) column chromatography by gradient elution with ethyl acetate/pet ether (10–25%).

Diisopropyl 1-(8-Methyl-3-(p-tolyl)-3,8-dihydro-2H-thieno[2,3-b]indol-2-yl)hydrazine-1,2-dicarboxylate (3a)

White solid; yield 155 mg, 46%; mp 158–160 °C; IR (KBr, cm–1): 3292 (br m), 2980 (m), 1720 (vs), 1384 (m), 1107 (s); 1H NMR (CDCl3, 500 MHz): δ 1.10–1.40 (br poorly resolved, 12H), 2.32 (s, 3H), 3.68 (s, 3H), 4.90–5.10 (br unresolved, 3H), 6.60 (br s, 1H), 6.72 (br unresolved d, 1H), 6.95 (br d, J = 7.3 Hz, 2H), 7.06 (t, J = 8.1 Hz, 1H), 7.11 (d, J = 7.3 Hz, 2H), 7.21 (d, J = 8.1 Hz, 1H), 7.24 (br unresolved, 2H); 13C NMR (CDCl3, 125 MHz): δ 21.2, 22.0, 22.1, 32.1, 50.8, 70.3, 71.6, 83.9, 109.0, 117.3, 117.5, 119.7, 119.8, 125.1, 127.5, 127.8, 129.5, 136.9, 138.0, 141.0, 154.5, 156.0; MS (ES+, Ar) m/z (rel intensity): 520 (MK+, 30), 504 (100), 482 (MH+, 40); HRMS (ES+): calcd for C26H31N3O4SNa (MNa+, 100), 504.1927; found, 504.1925.

Diisopropyl 1-(8-Methyl-3-(p-tolyl)-8H-thieno[2,3-b]indol-2-yl)hydrazine-1,2-dicarboxylate (4a)

White solid; yield 261 mg, 78%; mp 192–194 °C; IR (KBr, cm–1): 3289 (br m), 2980 (m), 1725 (vs), 1483 (m), 1469 (m), 1372 (m), 1306 (m), 1241 (m), 1180 (m), 1106 (s), 1038 (m), 742 (s); 1H NMR (CDCl3, 500 MHz): δ 1.14 (br unresolved d, 6H), 1.25–1.40 (br unresolved, 6H), 2.45 (s, 3H), 3.84 (s, 3H), 4.90–5.00 (br unresolved m, 1H), 5.00–5.10 (br unresolved m, 1H), 6.90 (br s, 1H), 7.07 (t, J = 8.0 Hz, 1H), 7.27 (t, J = 8.0 Hz, 1H), 7.31 (d, J = 7.7 Hz, 2H), 7.37 (d, J = 8.0 Hz, 1H), 7.49 (d, J = 7.7 Hz, 2H), 7.58 (d, J = 8.0 Hz, 1H); 13C NMR (CDCl3, 125 MHz): δ 21.5, 21.8, 22.1, 32.2, 70.4, 71.6, 109.1, 117.8, 119.2, 119.4, 122.2, 122.9, 128.7, 129.5, 131.5, 133.2, 133.8, 137.8, 141.5, 142.0, 155.7, 156.0; MS (ES+, Ar) m/z (rel intensity): 518 (MK+, 85), 502 (MNa+, 100), 480 (MH+, 6), 377 (18); HRMS (ES+): calcd for C26H29N3O4SNa (MNa+, 100), 502.1771; found, 502.1778.

Diisopropyl 1-(8-Methyl-3-phenyl-8H-thieno[2,3-b]indol-2-yl)hydrazine-1,2-dicarboxylate (4b)

White solid; yield 189 mg, 58%; mp 179–172 °C; IR (KBr, cm–1): 3291 (br w), 2980 (m), 1724 (s), 1482 (s), 1466 (s), 1374 (m), 1304 (m), 1244 (s), 1106 (s), 740 (m); 1H NMR (CDCl3, 500 MHz): δ 1.11 (br unresolved d, 6H), 1.25–1.40 (br unresolved, 6H), 3.84 (s, 3H), 4.90–5.00 (br unresolved m, 1H), 5.00–5.10 (br unresolved m, 1H), 7.01 (br s), 7.08 (t, J = 8.0 Hz, 1H), 7.28 (t, J = 8.0 Hz, 1H), 7.37 (d, J = 8.0 Hz, 1H), 7.43 (t, J = 7.6 Hz, 1H), 7.52 (t, J = 7.6 Hz, 2H), 7.57 (d, J = 8.0 Hz, 1H), 7.63 (d, J = 7.6 Hz, 2H); 13C NMR (CDCl3, 125 MHz): δ 21.8, 22.1, 32.2, 70.4, 71.6, 109.1, 117.7, 119.1, 119.4, 122.2, 122.8, 128.0, 128.8, 128.9, 129.2, 133.1, 134.5, 141.5, 142.0, 155.6, 156.1; MS (ES+, Ar) m/z (rel intensity): 504 (MK+, 100); HRMS (ES+): calcd for C25H27N3O4SK (MK+, 100), 504.1354; found, 504.1355.

Diisopropyl 1-(3-(4-Methoxyphenyl)-8-methyl-8H-thieno[2,3-b]indol-2-yl)hydrazine-1,2-dicarboxylate (4c)

White solid; yield 229 mg, 66%; mp 96–98 °C; IR (KBr, cm–1): 3304 (br m), 2980 (m), 1726 (s), 1726 (vs), 1486 (m), 1246 (s), 1107 (m); 1H NMR (CDCl3, 500 MHz): δ 1.13 (br unresolved, 6H), 1.27 (d, J = 6.2 Hz, 6H), 3.84 (s, 3H), 3.89 (s, 3H), 4.90–5.08 (unresolved m, 2H), 6.85 (br s, 1H), 7.02 (d, J = 8.6 Hz, 2H), 7.06 (t, J = 7.5 Hz, 1H), 7.26 (t, J = 7.5 Hz, 1H), 7.37 (d, J = 8.6 Hz, 2H), 7.51 (d, J = 7.5 Hz, 1H), 7.56 (d, J = 7.5 Hz, 1H); 13C NMR (CDCl3, 125 MHz): δ 21.9, 22.1, 32.2, 55.5, 70.1, 71.6, 109.1, 114.3, 117.9, 119.1, 119.4, 122.2, 122.9, 126.8, 128.6, 130.1, 132.9, 141.5, 142.0, 155.8, 156.0, 159.4; MS (ES+, Ar) m/z (rel intensity): 534 (MK+, 32), 518 (MNa+, 30) 496 (100); HRMS (ES+): calcd for C26H30N3O5S (MH+, 100), 496.1901; found, 496.1911.

Diisobutyl 1-(3-(4-Methoxyphenyl)-8-methyl-8H-thieno[2,3-b]indol-2-yl)hydrazine-1,2-dicarboxylate (4d)

White solid; yield 275 mg, 75%; mp 201–203 °C; IR (KBr, cm–1): 3302 (br w), 2979 (m), 1725 (s), 1482 (s), 1247 (s), 1159 (vs); 1H NMR (CDCl3, 500 MHz): δ 1.30, 1.53 (s, 18H), 3.84 (s, 3H), 3.89 (s, 3H), 6.90 (br s, 1H), 7.03–7.12 (br unresolved, 3H), 7.25–7.31 (br unresolved, 1H), 7.35–7.40 (br unresolved, 1H), 7.54–7.66 (br unresolved, 3H); 13C NMR (CDCl3, 125 MHz): δ 28.0, 28.3, 32.2, 55.4, 81.9, 82.5, 109.1, 114.2, 117.7, 119.1, 119.3, 122.0, 122.9, 127.0, 129.5, 130.0, 132.2, 141.4, 141.9, 154.6, 155.5, 159.3; MS (ES+, Ar) m/z (rel intensity): 562 (MK+, 100); HRMS (ES+): calcd for C28H33N3O5SK (MK+, 100), 562.1773; found, 562.1769.

Diisopropyl 1-(3-(4-Chlorophenyl)-8-methyl-8H-thieno[2,3-b]indol-2-yl)hydrazine-1,2-dicarboxylate (4e)

White solid; yield 231 mg, 66%; mp 164–166 °C; IR (KBr, cm–1): 3284 (br w), 2980 (w), 1725 (vs), 1481 (m), 1466 (m), 1374 (m), 1306 (m), 1245 (m), 1105 (s), 741 (m); 1H NMR (CDCl3, 500 MHz): δ 1.12 (br unresolved d, 6H), 1.20–1.40 (br unresolved, 6H), 3.85 (s, 3H), 4.90–5.00 (br unresolved m, 1H), 5.00–5.10 (br unresolved m, 1H), 6.91 (br s, 1H), 7.07 (t, J = 7.9 Hz, 1H), 7.28 (t, J = 7.9 Hz, 1H), 7.37 (d, J = 7.9 Hz, 1H), 7.48 (d, J = 8.2 Hz, 2H), 7.51 (d, J = 8.2 Hz, 2H), 7.53–7.57 (br unresolved, 1H); 13C NMR (CDCl3, 125 MHz): δ 21.9, 22.2, 32.3, 70.6, 71.8, 109.3, 117.6, 119.0, 119.6, 122.4, 122.7, 129.1, 129.7, 130.3, 132.0, 133.0, 134.0, 141.6, 142.2, 155.6, 156.2; MS (ES+, Ar) m/z (rel intensity): 524 ([MNa+2]+, 11), 526 (MNa+, 40), 502 ([MH+2]+, 35), 500 (MH+, 100); HRMS (ES+): calcd for C25H27N3O4SCl (MH+, 100), 500.1405; found, 500.1404.

Diisopropyl 1-(8-Methyl-3-(thiophen-2-yl)-8H-thieno[2,3-b]indol-2-yl)hydrazine-1,2-dicarboxylate (4f)

White solid; yield 132 mg, 40%; mp 145–147 °C; IR (KBr, cm–1): 3299 (br w), 2980 (w), 1728 (vs), 1599 (w), 1480 (m), 1237 (m), 1105 (m); 1H NMR (CDCl3, 500 MHz): δ 1.13 (br d, J = 5.3 Hz, 6H), 1.35–1.45 (br unresolved, 6H), 3.83 (s, 3H), 4.95–5.00 (br m, 1H), 5.02–5.12 (br unresolved m, 1H), 7.06 (br s, 1H), 7.15 (t, J = 7.9 Hz, 1H), 7.21 (dd, J = 4.7, 4.2 Hz, 1H), 7.31 (t, J = 7.9 Hz, 1H), 7.38 (d, J = 7.9 Hz, 1H), 7.42 (d, J = 4.7 Hz, 1H), 7.50 (br unresolved, 1H), 7.92 (d, J = 7.9 Hz, 1H); 13C NMR (CDCl3, 125 MHz): δ 21.8, 22.1, 32.2, 70.5, 71.8, 109.2, 117.1, 119.4, 119.5, 122.4, 122.6, 126.0, 126.1, 127.2, 127.4, 129.3, 134.8, 141.5, 142.0, 155.5, 156.0; MS (ES+, Ar) m/z (rel intensity): 510 (MK+, 100); HRMS (ES+): calcd for C23H25N3O4S2K (MK+, 100), 510.0918; found, 510.0919.

Diisopropyl 1-(8-Ethyl-3-(p-tolyl)-8H-thieno[2,3-b]indol-2-yl)hydrazine-1,2-dicarboxylate (4g)

White solid; yield 148 mg, 43%; mp 184–186 °C; IR (KBr, cm–1): 3289 (br m), 2980 (s), 1726 (vs), 1479 (s), 1466 (s), 1374 (m), 1302 (m), 1242 (s), 1181 (m), 1106 (s), 1038 (m), 740 (m); 1H NMR (CDCl3, 500 MHz): δ 1.11 (br unresolved d, 6H), 1.20–1.40 (br resolved, 6H), 1.51 (t, J = 7.2 Hz, 3H), 2.43 (s, 3H), 4.26 (q, J = 7.2 Hz, 2H), 4.88–4.95 (br unresolved m, 1H), 4.98–5.08 (br unresolved, 1H), 6.84 (br s, 1H), 7.03 (t, J = 8.1 Hz, 1H), 7.24 (t, J = 8.1 Hz, 1H), 7.28 (d, J = 7.2 Hz, 2H), 7.37 (d, J = 8.1 Hz, 1H), 7.46 (br d, J = 7.2 Hz, 2H), 7.55 (d, J = 8.1 Hz, 1H), no appreciable change in the pattern even at 328 K, see VT NMR spectra; 13C NMR (CDCl3, 125 MHz): δ 13.9, 21.4, 21.8, 22.0, 40.8, 70.3, 71.5, 109.1, 118.1, 119.2, 122.0, 122.9, 128.7, 129.4, 131.4, 133.1, 133.6, 137.7, 140.4, 155.6, 156.0; MS (ES+, Ar) m/z (rel intensity): 532 (MK+, 100), 516 (MNa+, 65), 494 (35); HRMS (ES+): calcd for C27H31N3O4SK (MK+, 100), 532.1667; found, 532.1665.

Diisopropyl 1-(8-Propyl-3-(p-tolyl)-8H-thieno[2,3-b]indol-2-yl)hydrazine-1,2-dicarboxylate (4h)

White solid; yield 230 mg, 65%; mp 169–171 °C; IR (KBr, cm–1): 3290 (br w), 2979 (m), 1726 (vs), 1478 (m), 1244 (m), 1107 (s); 1H NMR (CDCl3, 500 MHz): δ 1.03 (t, J = 7.2 Hz, 3H), 1.14 (br unresolved d, 6H), 1.25–1.40 (br unresolved, 6H), 1.99 (sextet, J = 7.2 Hz, 2H), 2.46 (s, 3H), 4.18 (t, J = 7.2 Hz, 2H), 4.92–4.98 (br unresolved m, 1H), 5.02–5.10 (br unresolved m, 1H), 6.95 (br s, 1H), 7.06 (t, J = 8.0 Hz, 1H), 7.26 (t, J = 8.0 Hz, 1H), 7.32 (d, J = 7.1 Hz, 2H), 7.40 (d, J = 8.0 Hz, 1H), 7.51 (d, J = 7.1 Hz, 2H), 7.60 (d, J = 8.0 Hz, 1H); 13C NMR (CDCl3, 125 MHz): δ 11.8, 21.5, 21.8, 22.1, 22.3, 47.9, 70.4, 71.5, 109.3, 118.0, 118.1, 119.2, 122.0, 122.9, 128.7, 129.5, 131.5, 133.1, 133.6, 137.7, 141.0, 141.2, 155.7, 156.1; MS (ES+, Ar) m/z (rel intensity): (MK+, 100); HRMS (ES+): calcd for C28H33N3O4SK (MK+, 100), 546.1823; found, 546.1821.

Diisopropyl 1-(8-Benzyl-3-(p-tolyl)-8H-thieno[2,3-b]indol-2-yl)hydrazine-1,2-dicarboxylate (4i)

White solid; yield 249 mg, 64%; mp 166–168 °C; IR (KBr, cm–1): 3278 (br m), 2980 (m), 1720 (vs), 1454 (m), 1373 (m), 1303 (s), 1244 (s), 1106 (s), 1037 (m), 738 (m); 1H NMR (CDCl3, 500 MHz): δ 1.13 (br unresolved d, 6H), 1.22–1.35 (br unresolved, 6H), 2.46 (s, 3H), 4.90–5.00 (br unresolved m, 1H), 5.00–5.08 (br unresolved m, 1H), 5.38 (s, 2H), 6.92 (br s, 1H), 7.08 (t, J = 7.5 Hz, 1H), 7.23–7.43 (m, 7H), 7.32 (d, J = 7.8 Hz, 2H), 7.51 (br d, J = 7.8 Hz, 2H), 7.62 (d, J = 7.5 Hz, 1H); 13C NMR (CDCl3, 125 MHz): δ 21.5, 21.9, 22.1, 50.0, 70.4, 71.5, 109.6, 118.5, 119.3, 119.6, 122.3, 123.1, 127.5, 127.8, 128.1, 128.8, 129.0, 129.4, 129.5, 131.4, 133.0, 135.9, 137.8, 141.2, 155.7, 155.9; MS (ES+, Ar) m/z (rel intensity): 612 ([MK + H2O]+, 25), 594 (MK+, 100), 578 (MNa+, 45); HRMS (ES+): calcd for C32H33N3O4SK (MK+, 100), 594.1823; found, 594.1825.

General Procedure for the Synthesis of Thienoindoles (6)

To a stirred solution of indoline-2-thione 1 (0.75 mmol, 1 equiv) and K2CO3 (104 mg, 0.75 mmol, 1 equiv) in CH3CN/H2O (97:3, 3 mL) at room temperature was added the RC adduct 5 (0.75 mmol, 1 equiv). After the completion of the reaction (monitored by TLC), the reaction mixture was concentrated in vacuo and the crude residue was purified by silica gel column chromatography by gradient elution with ethyl acetate/pet ether (10–25%).

4-(8-Methyl-2-phenyl-8H-thieno[2,3-b]indol-3-yl)butan-2-one (6a)

White solid; yield 189 mg, 76%; mp 129–131 °C; IR (KBr, cm–1): 3052 (w), 2922 (m), 1715 (vs), 1590 (m), 1360 (m), 1330 (s), 1163 (m), 743 (s); 1H NMR (CDCl3, 500 MHz): δ 2.10 (s, 3H), 2.76 (t, J = 7.4 Hz, 2H), 3.15 (t, J = 7.4 Hz, 2H), 3.80 (s, 3H), 6.99 (t, J = 8.2 Hz, 1H), 7.21 (t, J = 8.2 Hz 1H), 7.30 (d, J = 8.2 Hz, 1H), 7.41–7.45 (m, 2H), 7.50 (t, J = 7.4 Hz, 2H), 7.55 (t, J = 7.4 Hz, 2H); 13C NMR (CDCl3, 125 MHz): δ 23.1, 30.1, 32.2, 45.9, 109.0, 118.9, 119.1, 121.7, 122.1, 122.4, 127.5, 128.7, 129.6, 130.2, 131.7, 136.1, 141.4, 142.0, 207.6; MS (ES+, Ar) m/z (rel intensity): 379 (M2Na+, 100), 372 (MK+, 70), 356 (MNa+, 80); HRMS (ES+): calcd for C21H19NOSK (MK+), 372.0819; found, 372.0825.

4-(8-Methyl-2-(p-tolyl)-8H-thieno[2,3-b]indol-3-yl)butan-2-one (6b)

White solid; yield 95 mg, 37%; mp 122–124 °C; IR (KBr, cm–1): 3050 (w), 2925 (m), 1715 (s), 1484 (m), 1465 (m), 1266 (m), 1162 (m), 822 (m), 740 (vs), 705 (m); 1H NMR (CDCl3, 500 MHz): δ 2.12 (s, 3H), 2.47 (s, 3H), 2.78 (t, J = 4.0 Hz, 2H), 3.15 (t, J = 4.0 Hz, 2H), 3.83 (s, 3H), 7.02 (t, J = 7.5 Hz, 1H), 7.23 (t, J = 7.5 Hz, 1H), 7.31–7.34 (m, 3H), 7.43–7.47 (m, 3H); 13C NMR (CDCl3, 125 MHz): δ 21.5, 23.2, 30.2, 32.2, 46.0, 109.0, 119.0, 119.1, 121.7, 122.3 (×2), 129.4, 129.5, 129.9, 131.7, 133.0, 137.2, 141.4, 142.0, 207.7; MS (ES+, Ar) m/z (rel intensity): 386 (MK+, 30), 370 (MNa+, 100); HRMS (ES+): calcd for C22H21NOSNa (MNa+), 370.1236; found, 370.1240.

4-(2-(4-Methoxyphenyl)-8-methyl-8H-thieno[2,3-b]indol-3-yl)butan-2-one (6c)

White solid; yield 95 mg, 35%; mp 132–134 °C; IR (KBr, cm–1): 3053 (w), 2930 (m), 1715 (s), 1610 (m), 1502 (s), 1490 (s), 1465 (s), 1245 (vs), 1174 (s), 1030 (s), 742 (vs); 1H NMR (CDCl3, 500 MHz): δ 2.13 (s, 3H), 2.78 (t, J = 7.4 Hz, 2H), 3.16 (t, J = 7.4 Hz, 2H), 3.83 (s, 3H), 3.91 (s, 3H), 7.03 (t, J = 8.1 Hz, 1H), 7.06 (d, J = 8.6 Hz, 2H), 7.24 (t, J = 8.1 Hz, 1H), 7.33 (d, J = 8.1 Hz, 1H), 7.45 (d, J = 8.1 Hz, 1H), 7.49 (d, J = 8.6 Hz, 2H); 13C NMR (CDCl3, 125 MHz): δ 23.2, 30.2, 32.2, 46.0, 55.5, 109.0, 114.1, 118.9, 119.1, 121.7, 122.2, 122.4, 128.3, 129.7, 130.7, 131.4, 141.3, 142.0, 159.1, 207.7; MS (ES+, Ar) m/z (rel intensity): 402 (MK+, 25), 386 (100), 364 (MH+, 20); HRMS (ES+): calcd for C22H21NO2SNa (MNa+), 386.1185; found, 386.1178.

4-(2-(3,4-Dimethoxyphenyl)-8-methyl-8H-thieno[2,3-b]indol-3-yl)butan-2-one (6d)

Brown sticky solid; yield 174 mg, 59%; IR (KBr, cm–1): 3054 (w), 2931 (m), 1714 (s), 1507 (s), 1487 (s), 1465 (s), 1260 (s), 1245 (s), 1026 (s), 742 (vs); 1H NMR (CDCl3, 500 MHz): δ 2.13 (s, 3H), 2.78 (t, J = 7.3 Hz, 2H), 3.19 (t, J = 7.3 Hz, 2H), 3.81 (s, 3H), 3.91 (s, 3H), 3.98 (s, 3H), 7.01 (t, J = 8.2 Hz, 1H), 7.04 (d, J = 7.3 Hz, 1H), 7.09 (dd, J = 7.3, 1.3 Hz, 1H), 7.14 (d, J = 1.3 Hz, 1H), 7.24 (t, J = 8.2 Hz, 1H), 7.33 (d, J = 8.2 Hz, 1H), 7.40 (d, J = 8.2 Hz, 1H); 13C NMR (CDCl3, 125 MHz): δ 23.1, 30.2, 32.2, 45.8, 56.0 (×2), 109.0, 111.2, 112.7, 118.8, 119.0, 121.7, 121.8, 122.1, 122.2, 128.5, 129.7, 131.3, 141.2, 141.9, 148.4, 148.9, 207.6; MS (ES+, Ar) m/z (rel intensity): 432 (MK+, 25), 416 (MNa+, 100); HRMS (ES+): calcd for C23H23NO3SNa (MNa+), 416.1291; found, 416.1298.

4-(2-(3-Methoxyphenyl)-8-methyl-8H-thieno[2,3-b]indol-3-yl)butan-2-one (6e)

White solid; yield 76 mg, 28%; mp 97–99 °C; IR (KBr, cm–1): 3052 (w), 2933 (m), 1714 (s), 1599 (m), 1578 (m), 1491 (s), 1465 (s), 1223 (m), 740 (vs); 1H NMR (CDCl3, 500 MHz): δ 2.14 (s, 3H), 3.80 (t, J = 7.3 Hz, 2H), 3.20 (t, J = 7.3 Hz, 2H), 3.83 (s, 3H), 3.88 (s, 3H), 7.00 (d, J = 7.8 Hz, 1H), 7.05 (t, J = 8.2 Hz, 1H), 7.15 (d, J = 7.8 Hz, 1H), 7.17 (s, 1H), 7.25 (t, J = 8.2 Hz, 1H), 7.34 (d, J = 8.2 Hz, 1H), 7.44 (t, J = 7.8 Hz, 1H), 7.49 (d, J = 8.2 Hz, 1H); 13C NMR (CDCl3, 125 MHz): δ 23.2, 30.2, 32.3, 46.0, 55.5, 109.1, 113.4, 115.0, 119.1, 119.2, 121.8, 122.1, 122.2, 129.7, 130.3, 131.6, 137.4, 141.4, 142.1, 159.9, 207.6; MS (ES+, Ar) m/z (rel intensity): 402 (MK+, 50), 386 (MNa+, 100), 364 (MH+, 5), 306 (5); HRMS (ES+): calcd for C22H21NO2SNa (MNa+), 386.1185; found, 386.1182.

4-(2-(3-(Benzyloxy)phenyl)-8-methyl-8H-thieno[2,3-b]indol-3-yl)butan-2-one (6f)

Brown sticky solid; yield 167 mg, 51%; IR (KBr, cm–1): 2928 (w), 1715 (s), 1713 (s), 1491 (m), 1465 (m), 1264 (m), 738 (vs); 1H NMR (CDCl3, 500 MHz): δ 2.14 (s, 3H), 2.77 (t, J = 7.3 Hz, 2H), 3.18 (t, J = 7.3 Hz, 2H), 3.83 (s, 3H), 5.16 (s, 2H), 7.06 (t, J = 7.0 Hz, 1H), 7.09 (dd, J = 7.5 Hz, J = 1.8 Hz, 1H), 7.21 (d, J = 7.5 Hz, 1H), 7.23 (t, J = 7.0 Hz, 1H), 7.26 (t, J = 7.5 Hz, 1H), 7.34–7.38 (m, 2H), 7.41 (t, J = 8.2 Hz, 2H), 7.46 (d, J = 7.0 Hz, 1H), 7.47–7.51 (m, 3H); 13C NMR (CDCl3, 125 MHz): δ 23.1, 30.1, 32.2, 45.9, 70.1, 109.0, 114.4, 115.8, 119.0, 119.1, 121.7, 122.0, 122.1, 122.3, 127.6, 128.1, 128.7, 129.7, 130.3, 131.4, 137.1, 137.4, 141.4, 142.0, 159.0, 207.6; MS (ES+, Ar) m/z (rel intensity): 478 (MK+, 50), 462 (MNa+, 100); HRMS (ES+): calcd for C28H25NO2SNa (MNa+), 462.1498; found, 462.1504.

4-(2-(2,5-Dimethoxyphenyl)-8-methyl-8H-thieno[2,3-b]indol-3-yl)butan-2-one (6g)

White solid; yield 205 mg, 70%; mp 131–133 °C; IR (KBr, cm–1): 2935 (m), 1714 (s), 1493 (m), 1465 (m), 1268 (m), 1218 (s), 1047 (s), 1024 (m), 738 (vs); 1H NMR (CDCl3, 500 MHz): δ 2.14 (s, 3H), 2.80 (t, J = 7.3 Hz, 2H), 3.08 (t, J = 7.3 Hz, 2H), 3.71 (s, 3H), 3.81 (s, 3H), 3.82 (s, 3H), 6.96–7.01 (m, 2H), 7.01–7.04 (m, 2H), 7.22 (t, J = 7.8 Hz, 1H), 7.30 (ABq collapsed to t, J = 9.0 Hz, 2H); 13C NMR (CDCl3, 125 MHz): δ 23.7, 30.1, 32.2, 45.6, 55.9, 56.3, 108.9, 112.7, 114.2, 117.1, 118.9, 119.0, 121.5, 122.4, 122.6, 125.6, 127.2, 131.2, 141.2, 141.9, 151.6, 153.7, 207.9; MS (ES+, Ar) m/z (rel intensity): 432 (MK+, 20), 416 (MNa+, 80), 394 (MH+, 35), 390 (100); HRMS (ES+): calcd for C23H23NO3SNa (MNa+), 416.1291; found, 416.1291.

4-(2-(4-Bromophenyl)-8-methyl-8H-thieno[2,3-b]indol-3-yl)butan-2-one (6h)

White solid; yield 142 mg, 46%; mp 122–124 °C; IR (KBr, cm–1): 3049 (w), 2925 (m), 1715 (vs), 1479 (s), 1465 (s), 1332 (m), 1162 (m), 827 (m), 741 (vs); 1H NMR (CDCl3, 500 MHz): δ 2.15 (s, 3H), 2.79 (t, J = 7.3 Hz, 2H), 3.15 (t, J = 7.3 Hz, 2H), 3.84 (s, 3H), 7.05 (t, J = 8.0 Hz, 1H), 7.26 (t, J = 8.0 Hz, 1H), 7.35 (d, J = 8.0 Hz, 1H), 7.41 (d, J = 8.0 Hz, 1H), 7.46 (d, J = 8.2 Hz, 2H), 7.66 (d, J = 8.2 Hz, 2H); 13C NMR (CDCl3, 125 MHz): δ 23.0, 30.2, 32.3, 45.8, 109.2, 118.8, 119.3, 121.6, 121.8, 121.9, 130.4, 130.6, 131.3, 131.9, 135.0, 141.5, 142.0, 207.4; MS (ES+, Ar) m/z (rel intensity): 452 ([MK+2]+, 15), 450 (MK+, 14), 436 [MNa+2]+, 100), 434 (MNa+, 98); (HRMS (ES+): calcd for C21H18NOSBrNa (MNa+), 434.0185; found, 434.0183.

4-(2-(4-Chlorophenyl)-8-methyl-8H-thieno[2,3-b]indol-3-yl)butan-2-one (6i)

White solid; yield 175 mg, 63%; mp 95–97 °C; IR (KBr, cm–1): 3051 (w), 2927 (m), 1715 (vs), 1481 (s), 1465 (s), 1332 (m), 1162 (m), 1088 (m), 829 (m), 740 (vs); 1H NMR (CDCl3, 500 MHz): δ 2.16 (s, 3H), 2.80 (t, J = 7.3 Hz, 2H), 3.17 (t, J = 7.3 Hz, 2H), 3.83 (s, 3H), 7.07 (t, J = 8.0 Hz, 1H), 7.28 (t, J = 8.0 Hz, 1H), 7.35 (d, J = 8.0 Hz, 1H), 7.44 (d, J = 8.0 Hz, 1H), 7.52–7.54 (unresolved m, 4H); 13C NMR (CDCl3, 125 MHz): δ 23.0, 30.1, 32.2, 45.7, 109.1, 118.7, 119.2, 121.8, 121.9, 128.9, 130.3, 130.6, 130.9, 133.4, 134.5, 141.4, 142.0, 207.3; MS (ES+, Ar) m/z (rel intensity): 408 ([MK+2]+, 20), 406 (MK+, 60), 392 ([MNa+2]+, 33), 390 (MNa+, 100); HRMS (ES+): calcd for C21H18ClNOSNa (MNa+), 390.0690; found, 390.0692.

4-(2-(4-Fluorophenyl)-8-methyl-8H-thieno[2,3-b]indol-3-yl)butan-2-one (6j)

White solid; yield 125 mg, 48%; mp 79–81 °C; IR (KBr, cm–1): 2928 (w), 1715 (vs), 1500 (s), 1465 (m), 1221 (s), 1158 (m), 742 (vs); 1H NMR (CDCl3, 500 MHz): δ 2.16 (s, 3H), 2.81 (t, J = 7.3 Hz, 2H), 3.17 (t, J = 7.3 Hz, 2H), 3.84 (s, 3H), 7.07 (t, J = 8.2 Hz, 1H), 7.24 (t, J = 8.2 Hz, 1H), 7.27 (dd, J = 7.7 Hz, J = 3.5 Hz, 2H), 7.36 (d, J = 8.2 Hz, 1H), 7.43 (d, J = 8.2 Hz, 1H), 7.56 (dd, J = 7.7, 5.6 Hz, 2H); 13C NMR (CDCl3, 125 MHz): δ 23.0, 30.1, 32.2, 45.8, 109.1, 115.7 (d, J = 21.3 Hz), 118.7, 119.2, 121.8, 122.0, 122.1, 130.3, 130.5, 131.2 (d, J = 8.8 Hz), 132.0 (d, J = 3.8 Hz), 141.3, 142.0, 162.3 (d, J = 245.0 Hz), 207.5; 19F NMR (CDCl3, 470 MHz): δ 114.7; MS (ES+, Ar) m/z (rel intensity): 390 (MK+, 55), 374 (MNa+, 100), 352 (MH+, 8), 294 (17); HRMS (ES+): calcd for C21H18FNOSNa (MNa+), 374.0985; found, 374.0989.

4-(8-Methyl-2-(naphthalen-1-yl)-8H-thieno[2,3-b]indol-3-yl)butan-2-one (6k)

White solid; yield 160 mg, 56%; mp 99–100 °C; IR (KBr, cm–1): 3054 (m), 2928 (m), 1715 (s), 1489 (m), 1464 (m), 1331 (m), 1265 (m), 1163 (m), 803 (m), 782 (s), 740 (vs), 703 (m); 1H NMR (CDCl3, 500 MHz): δ 2.0 (s, 3H), 2.68, 2.72 (ABqdd, J = 17.7, 7.1, 6.6 Hz, 2H), 3.00 (ddd, J = 15.1, 7.1, 6.6 Hz, 1H), 3.09 (ddd, J = 15.1, 7.1, 6.6 Hz, 1H), 3.88 (s, 3H), 6.68 (d, J = 7.9 Hz, 1H), 6.83 (t, J = 7.9 Hz, 1H), 7.18 (t, J = 7.9 Hz, 1H), 7.33 (d, J = 7.9 Hz, 1H), 7.36 (t, J = 7.2 Hz, 1H), 7.53 (t, J = 7.2 Hz, 1H), 7.59 (d, J = 7.1 Hz, 1H), 7.63 (t, J = 7.1 Hz, 1H), 7.78 (d, J = 7.2 Hz, 1H), 7.98 (d, J = 7.2 Hz, 1H), 7.99 (d, J = 7.1 Hz, 1H); 13C NMR (CDCl3, 125 MHz): δ 23.4, 30.0, 32.3, 45.8, 108.9, 119.0, 119.1, 121.6, 122.1, 123.5, 125.7, 126.1, 126.3, 126.4, 127.7, 128.3, 128.4, 129.6, 131.4, 132.4, 133.8, 133.9, 141.2, 141.9, 207.6; MS (ES+, Ar) m/z (rel intensity): 422 (MK+, 100), 406 (MNa+, 50); HRMS (ES+): calcd for C25H21NOSK (MK+), 422.0975; found, 422.0995. Confirmed by 1H1H COSY experiments.

4-(8-Methyl-2-(thiophen-2-yl)-8H-thieno[2,3-b]indol-3-yl)butan-2-one (6l)

Brown sticky solid; yield 80 mg, 31%; IR (KBr, cm–1): 3050 (vw), 2924 (w), 1714 (vs), 1491 (m), 1464 (m), 1332 (m), 1162 (m), 742 (vs), 702 (s); 1H NMR (CDCl3, 500 MHz): δ 2.16 (s, 3H), 2.83 (t, J = 7.4 Hz, 2H), 3.25 (t, J = 7.4 Hz, 2H), 3.83 (s, 3H), 7.08 (td, J = 8.2, 0.8 Hz, 1H), 7.21 (dd, J = 3.5, 1.6 Hz, 1H), 7.26 (td, J = 8.2, 0.8 Hz, 1H), 7.27 (d, J = 1.6 Hz, 1H), 7.34 (br d, J = 8.2 Hz, 1H), 7.45 (dd, J = 5.2, 3.5 Hz, 1H), 7.67 (br d, J = 8.2 Hz, 1H); 13C NMR (CDCl3, 125 MHz): δ 23.4, 30.2, 32.2, 46.0, 109.1, 119.1, 119.2, 121.9, 122.0, 122.2, 124.0, 125.7, 127.3, 127.4, 132.0, 136.5, 141.2, 142.0, 207.7; MS (ES+, Ar) m/z (rel intensity): 362 (MNa+, 95), 340 (MH+, 100); HRMS (ES+): calcd for C19H18NOS2 (MH+), 340.0824; found, 340.0825.

4-(8-Ethyl-2-phenyl-8H-thieno[2,3-b]indol-3-yl)butan-2-one (6m)

White solid; yield 225 mg, 87%; mp 79–87 °C; IR (KBr, cm–1): 3052 (w), 2976 (m), 2931 (w), 1715 (vs), 1485 (s), 1467 (m), 1452 (m), 1336 (m), 1163 (m), 742 (vs); 1H NMR (CDCl3, 500 MHz): δ 1.52 (t, J = 7.2 Hz, 3H), 2.13 (s, 3H), 2.79 (t, J = 7.4 Hz, 2H), 3.16 (t, J = 7.4 Hz, 2H), 4.26 (q, J = 7.2 Hz, 2H), 7.00 (t, J = 8.2 Hz, 1H), 7.22 (t, J = 8.2 Hz, 1H), 7.35 (d, J = 8.2 Hz, 1H), 7.41 (d, J = 8.2 Hz, 1H), 7.43 (overlapped t, J = 7.4 Hz, 1H), 7.51 (t, J = 7.4 Hz, 2H), 7.56 (d, J = 7.4 Hz, 2H); 13C NMR (CDCl3, 125 MHz): δ 14.1, 23.1, 30.2, 40.8, 46.0, 109.1, 118.9, 119.0, 121.7, 122.2, 122.5, 127.5, 128.7, 129.6, 130.2, 131.6, 136.0, 139.9, 141.0, 207.7; MS (ES+, Ar) m/z (rel intensity): 386 (MK+, 20), 370 (MNa+, 55), 348 (MH+, 100); HRMS (ES+): calcd for C22H22NOS (MH+), 348.1417; found, 348.1411.

4-(2-Phenyl-8-propyl-8H-thieno[2,3-b]indol-3-yl)butan-2-one (6n)

Brown sticky solid; yield 150 mg, 55%; IR (KBr, cm–1): 2964 (w), 1714 (s), 1646 (s), 1484 (m), 1460 (m), 740 (vs), 703 (m); 1H NMR (CDCl3, 500 MHz): δ 1.03 (t, J = 7.2 Hz, 3H), 1.99 (sextet, J = 7.2 Hz, 2H), 2.14 (s, 3H), 2.81 (t, J = 7.4 Hz, 2H), 3.19 (t, J = 7.4 Hz, 2H), 4.18 (t, J = 7.2 Hz, 2H), 7.03 (t, J = 7.5 Hz, 1H), 7.24 (t, J = 7.5 Hz, 1H), 7.37 (d, J = 7.5 Hz), 7.45 (d, J = 7.5 Hz, 1H), 7.46 (overlapped t, J = 7.6 Hz, 1H), 7.54 (t, J = 7.6 Hz, 2H), (d, J = 7.6 Hz, 2H); 13C NMR (CDCl3, 125 MHz): δ 11.9, 22.5, 23.0, 30.1, 45.9, 47.8, 109.2, 118.9, 119.0, 121.6, 122.1, 122.3, 127.5, 128.7, 129.6, 130.1, 131.5, 136.0, 140.5, 141.5, 207.7; MS (ES+, Ar) m/z (rel intensity): 400 (MK+, 20), 384 (MNa+, 50), 378 (55), 360 ([M – 1]+, 100); HRMS (ES+): calcd for C23H23NOSNa (MNa+), 384.1393; found, 384.1394.

4-(8-Benzyl-2-phenyl-8H-thieno[2,3-b]indol-3-yl)butan-2-one (6o)

White solid; yield 287 mg, 94%; mp 100–102 °C; IR (KBr, cm–1): 3055 (m), 2919 (w), 1714 (vs), 1481 (s), 1456 (s), 1359 (m), 1336 (m), 1162 (m), 781 (m), 736 (vs), 703 (vs); 1H NMR (CDCl3, 500 MHz): δ 2.11 (s, 3H), 2.76 (t, J = 7.5 Hz, 2H), 3.15 (t, J = 7.5 Hz, 2H), 5.37 (s, 2H), 7.06 (t, J = 7.6 Hz, 1H), 7.24 (t, J = 7.6 Hz, 1H), 7.29–7.32 (m, 2H), 7.33–7.41 (m, 4H), 7.44–7.51 (m, 2H), 7.55 (t, J = 7.9 Hz, 2H), 7.60 (d, J = 7.9 Hz, 2H); 13C NMR (CDCl3, 125 MHz): δ 23.0, 30.1, 45.9, 49.8, 109.5, 119.0, 119.3, 121.9, 122.4, 122.9, 127.5, 127.6, 128.1, 128.7, 129.0, 129.6, 130.7, 131.4, 135.9, 136.0, 140.5, 141.7, 207.6; MS (ES+, Ar) m/z (rel intensity): 448 (MK+, 45), 432 (MNa+, 100); HRMS (ES+): calcd for C27H23NOSNa (MNa+), 432.1393; found, 432.1396.

4-(5-Chloro-8-methyl-2-phenyl-8H-thieno[2,3-b]indol-3-yl)butan-2-one (6p)

Brown sticky solid; yield 122 mg, 44%; IR (KBr, cm–1): 3055 (w), 2924 (m), 1715 (vs), 1488 (s), 1474 (s), 1362 (m), 1309 (m), 1163 (m), 924 (m), 793 (s), 739 (m); 1H NMR (CDCl3, 500 MHz): δ 2.12 (s, 3H), 2.77 (t, J = 7.4 Hz, 2H), 3.15 (t, J = 7.4 Hz, 2H), 3.79 (s, 3H), 7.16, 7.21 (ABq, J = 7.5 Hz, 2H), 7.35 (s, 1H), 7.43–7.46 (unresolved m, 1H), 7.51–7.54 (m, 4H); 13C NMR (CDCl3, 125 MHz): δ 23.1, 30.2, 32.4, 45.9, 109.9, 118.5, 121.5, 121.8, 122.9, 124.8, 127.8, 128.9, 129.4, 130.8, 131.5, 135.6, 140.4, 142.6, 207.5; MS (ES+, Ar) m/z (rel intensity): 408 ([MK+2]+, 5), 406 (MK+, 15), 392 (MNa+2]+, 33), 390 (MNa+, 100); HRMS (ES+): calcd for C21H18NOSClNa (MNa+), 390.0690; found, 390.0690.

4-(3-Phenyl-8H-thieno[2,3-b]indol-2-yl)butan-2-one (6q)

White solid; yield 105 mg, 44%; mp 144–146 °C; IR (KBr, cm–1): 3390 (br vs), 2962 (s), 2931 (m), 1728 (vs), 1619 (vs), 1506 (m), 1440 (m), 1286 (m), 1246 (vs), 1027 (m), 820 (m), 765 (m); 1H NMR (CDCl3, 400 MHz): δ 2.13 (s, 3H), 2.79 (t, J = 7.4 Hz, 2H), 3.19 (t, J = 7.4 Hz, 2H), 7.05 (t, J = 8.1 Hz, 1H), 7.20 (t, J = 8.1 Hz, 1H), 7.34 (d, J = 8.1 Hz, 1H), 7.45 (t, J = 7.3 Hz, 1H), 7.47 (d, J = 8.1 Hz, 1H), 7.54 (t, J = 7.3 Hz, 2H), 7.59 (d, J = 7.3 Hz, 2H), 8.56 (br s, 1H); 13C NMR (CDCl3, 100 MHz): δ 23.0, 30.1, 45.9, 111.4, 118.8, 119.5, 122.1, 122.3, 124.4, 127.5, 128.7, 129.6, 130.7, 131.1, 135.9, 138.1, 141.8, 208.3; MS (ES+, Ar) m/z (rel intensity): 342 (MNa+, 100); HRMS (ES+): calcd for C20H17NOSNa (MNa+), 342.0923; found, 342.0928.

Procedure for the Synthesis of Pyrazole-Containing Thieno[2,3-b]indole (8)

To a stirred solution of hydrazinothienoindole 4d (54 mg, 0.103 mmol, 1 equiv) in n class="Chemical">MeOH (1.5 mL) was added 4N HCl in dioxane (0.77 mL, 3.093 mmol, 30 equiv) at room temperature. The reaction mixture was stirred for 10 min, and then, acetyl acetone 7 (21 mg, 0.206 mmol, 2 equiv) was added and the mixture was stirred at room temperature for 12 h. After completion of the reaction (monitored by TLC), the solvent was removed in vacuo and the crude product was partitioned between EtOAc (10 mL) and sat aq NaHCO3 (10 mL). The organic phase was separated, washed with brine (10 mL), dried over anhydrous sodium sulphate, and concentrated in vacuo. The crude product was purified by silica gel column chromatography by gradient elution with ethyl acetate-pet ether (15–20%).

2-(3,5-Dimethyl-1H-pyrazol-1-yl)-3-(4-methoxyphenyl)-8-methyl-8H-thieno[2,3-b]indole (8)

Brown solid; yield 19 mg, 48%; mp 175–177 °C; IR (KBr, cm–1): 1647 (s), 1612 (s), 1248 (m), 1029 (m), 739 (vs); 1H NMR (CDCl3, 500 MHz): 1.77 (s, 3H), 2.33 (s, 3H), 3.84 (s, 3H), 3.87 (s, 3H), 5.82 (s, 1H), 6.92 (d, J = 8.5 Hz, 2H), 7.11 (t, J = 7.5 Hz, 1H), 7.31 (t, J = 7.5 Hz, 1H), 7.40 (d, J = 8.5 Hz, 2H and d, J = 7.5 Hz, 1H overlapped), 7.75 (d, J = 7.5 Hz, 1H); 13C NMR (CDCl3, 125 MHz): δ 11.4, 13.9, 32.4, 55.4, 106.0, 109.3, 114.2, 118.3, 119.5, 119.6, 122.5, 122.9, 124.7, 126.3, 132.9, 141.1, 141.7, 143.5 (×2), 149.8, 159.4; MS (ES+, Ar) m/z (rel intensity): 410 (MNa+, 5), 388 (MH+, 100), HRMS (ES+): calcd for C23H22N3OS (MH+), 388.1478; found, 388.1475.
  2 in total

Review 1.  Recent advances in the synthesis of thienoindole analogs and their diverse applications.

Authors:  Shubham Pandey; Simran Aggarwal; Ritu Choudhary; Satish K Awasthi
Journal:  RSC Adv       Date:  2022-05-25       Impact factor: 4.036

2.  Highly diastereoselective cascade [5 + 1] double Michael reaction, a route for the synthesis of spiro(thio)oxindoles.

Authors:  Firouz Matloubi Moghaddam; Vahid Saberi; Ashkan Karimi
Journal:  Sci Rep       Date:  2021-11-24       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.